---
title: "MDR rule 6: Surgically invasive devices for transient use"
url: https://normiq.app/en/classification/mdr/rule-6
language: en
updated: 2026-11-15
---

# MDR rule 6: Surgically invasive devices for transient use

MDR · Annex VIII, Section 5.2 · INVASIVE DEVICES

Updated on November 15, 2026

## Official text

All surgically invasive devices intended for transient use are classified as class IIa unless they:

- are intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with those parts of the body, in which case they are classified as class III;
- are reusable surgical instruments, in which case they are classified as class I;
- are intended specifically for use in direct contact with the heart or central circulatory system or the central nervous system, in which case they are classified as class III;
- are intended to supply energy in the form of ionising radiation in which case they are classified as class IIb;
- have a biological effect or are wholly or mainly absorbed in which case they are classified as class IIb; or
- are intended to administer medicinal products by means of a delivery system, if such administration of a medicinal product is done in a manner that is potentially hazardous taking account of the mode of application, in which case they are classified as class IIb.

MDR, Annex VIII, Section 5.2, consolidated version of July 19, 2026.

Short link: [normiq.app/en/mdr/annexe/viii/6](https://normiq.app/en/mdr/annexe/viii/6)

## In plain words

A surgically invasive device intended for transient use is in class IIa, with listed exceptions: class III in direct contact with the heart, the central circulatory system or the central nervous system, or to control, diagnose, monitor or correct a defect of the heart or central circulatory system through direct contact; class IIb to supply energy in the form of ionising radiation, if it has a biological effect or is wholly or mainly absorbed, or if it administers medicinal products in a potentially hazardous manner; class I for reusable surgical instruments.

Explanation written by Normiq; only the official text above is authoritative.

## Definitions the rule relies on

- MDR, Article 2, point 6

  ‘invasive device’ means any device which, in whole or in part, penetrates inside the body, either through a body orifice or through the surface of the body;

- MDR, Annex VIII, Section 2.1

  ‘Body orifice’ means any natural opening in the body, as well as the external surface of the eyeball, or any permanent artificial opening, such as a stoma.

- MDR, Annex VIII, Section 2.2

  ‘Surgically invasive device’ means:

  - an invasive device which penetrates inside the body through the surface of the body, including through mucous membranes of body orifices with the aid or in the context of a surgical operation; and
  - a device which produces penetration other than through a body orifice.

- MDR, Article 2, point 5

  ‘implantable device’ means any device, including those that are partially or wholly absorbed, which is intended:

  - to be totally introduced into the human body, or
  - to replace an epithelial surface or the surface of the eye,
  - by clinical intervention and which is intended to remain in place after the procedure.
  - Any device intended to be partially introduced into the human body by clinical intervention and intended to remain in place after the procedure for at least 30 days shall also be deemed to be an implantable device;

- MDR, Annex VIII, Section 1.1

  ‘Transient’ means normally intended for continuous use for less than 60 minutes.

- MDR, Annex VIII, Section 1.2

  ‘Short term’ means normally intended for continuous use for between 60 minutes and 30 days.

- MDR, Annex VIII, Section 1.3

  ‘Long term’ means normally intended for continuous use for more than 30 days.

- MDR, Annex VIII, Section 3.6

  In calculating the duration referred to in Section 1, continuous use shall mean:

  - the entire duration of use of the same device without regard to temporary interruption of use during a procedure or temporary removal for purposes such as cleaning or disinfection of the device. Whether the interruption of use or the removal is temporary shall be established in relation to the duration of the use prior to and after the period when the use is interrupted or the device removed; and
  - the accumulated use of a device that is intended by the manufacturer to be replaced immediately with another of the same type.

- MDR, Annex VIII, Section 2.6

  ‘Central circulatory system’ means the following blood vessels: arteriae pulmonales, aorta ascendens, arcus aortae, aorta descendens to the bifurcatio aortae, arteriae coronariae, arteria carotis communis, arteria carotis externa, arteria carotis interna, arteriae cerebrales, truncus brachiocephalicus, venae cordis, venae pulmonales, vena cava superior and vena cava inferior.

- MDR, Annex VIII, Section 2.3

  ‘Reusable surgical instrument’ means an instrument intended for surgical use in cutting, drilling, sawing, scratching, scraping, clamping, retracting, clipping or similar procedures, without a connection to an active device and which is intended by the manufacturer to be reused after appropriate procedures such as cleaning, disinfection and sterilisation have been carried out.

- MDR, Annex VIII, Section 2.7

  ‘Central nervous system’ means the brain, meninges and spinal cord.

## Examples from the MDCG guidance

The guidance lists these examples under rule 6 (MDCG 2021-24 Rev.1). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 3.1).

### Class I

- Scalpels and scalpel handles

  MDCG 2021-24 Rev.1, 4.2, Rule 6, p. 36

### Class IIa

- Needles or syringes

  MDCG 2021-24 Rev.1, 4.2, Rule 6, p. 35

### Class III

- Neuro-endoscopes

  MDCG 2021-24 Rev.1, 4.2, Rule 6, p. 36

## Classes and Normiq roadmaps

Rule 6 assigns: Class I, Class IIa, Class IIb, Class III. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class I

- [European Union 14 phases · 63 steps · estimated duration 210 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-i)
- [Switzerland 14 phases · 69 steps · estimated duration 60 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-i)
- [European Union and Switzerland 15 phases · 77 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-i)

### Class IIa

- [European Union 15 phases · 66 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iia)
- [Switzerland 16 phases · 74 steps · estimated duration 120 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iia)
- [European Union and Switzerland 17 phases · 82 steps · estimated duration 300 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iia)

### Class IIb

- [European Union 15 phases · 68 steps · estimated duration 360 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iib)
- [Switzerland 16 phases · 77 steps · estimated duration 180 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iib)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 420 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iib)

### Class III

- [European Union 15 phases · 68 steps · estimated duration 540 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iii)
- [Switzerland 16 phases · 77 steps · estimated duration 270 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iii)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 630 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iii)

## The same rule in Switzerland

> Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-MDR, taking account of the implementing acts of the European Commission listed in Annex 5a.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 15 MedDO](https://www.fedlex.admin.ch/eli/cc/2020/552/en#art_15)

The families of rules, the cross-cutting criteria, Rule 11 and common pitfalls are explained in the guide: [MDR classification: the 22 rules of Annex VIII explained](https://normiq.app/en/guides/classification-mdr-annexe-viii)

## Classify your device

The tool asks the questions of the 22 rules of the MDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [MDR, consolidated version of July 19, 2026 (02017R0745-20260719), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20260719)
- [MDCG 2021-24 Rev.1, “Guidance on classification of medical devices”, April 2026, p. 35, 36](https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf)
